Crystalline solid forms of a BET inhibitor
US11091480B2 · kind B2 · utility
6Cited by
29References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2020 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | May 19, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to crystalline solid forms of an inhibitor of BET proteins such as BRD2, BRD3, BRD4, and BRD-t, including methods of preparation thereof, and intermediates in the preparation thereof, where the compound is useful in the treatment of diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.